← FDA Drug Approvals (Drugs@FDA)

NELARABINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XGEN PHARMS · Approved 2024-09-05

Drug application

FDA Application #

ANDA216510

Application type

Abbreviated New Drug Application (Generic)

Brand name

NELARABINE

Generic name

NELARABINE

Active ingredients

NELARABINE

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

XGEN PHARMS

Manufacturer

XGen Pharmaceuticals DJB, Inc.

First approval

2024-09-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown